Konsume
Interval Day Week Month
Newswire Search Past 90 Days 16 stories 8 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View

Related Topics
Topic # Mentions Topic Reach
Prominent Journalists
Byline Articles Written Avg Reach
RTTNews Staff Writer 5 -
University of Texas M. D. Anderson Cancer CenterOct 26 2026Reviewed 1 -
OncotargetAug 28 2026Reviewed 1 -
Meghana Keshavan 1 -
Sam Robinson 1 -
UT Southwestern Medical CenterAug 9 2026Reviewed 1 -
Ben Hensley 1 -
by PR Newswire 1 -
Frank Vinluan 1 -
Murray Ward 1 -
Mayo ClinicOct 23 2026Reviewed 1 -
Adam Feuerstein, Andrew Joseph 1 -


Roche gets a lung cancer win with its KRAS drug divarasib

Adam Feuerstein, Andrew Joseph — statnews.com


Next generation KRAS inhibitor divarasib significantly extends lung cancer survival

University of Texas M. D. Anderson Cancer CenterOct 26 2026Reviewed — news-medical.net


Roche's Divarasib Cuts Death Risk By 44% In KRAS G12C-Mutated Lung Cancer Phase III Trial

RTTNews Staff Writer — rttnews.com


Genmab, Incyte Partner On Trial Of Petosemtamab Combination In KRAS G12D-Mutated Colorectal Cancer

RTTNews Staff Writer — rttnews.com


KRAS-targeting vaccine prompts immune responses in pancreatic cancer patients

Mayo ClinicOct 23 2026Reviewed — news-medical.net


Amplia uncovers new clue in pancreatic cancer drug trial

Murray Ward — brisbanetimes.com.au


Actinium Brings ATNM-400's Next-Generation Radiotherapy Approach To EANM 2026

RTTNews Staff Writer — rttnews.com


Verastem's KRAS inhibitor shows promise in pancreatic cancer

Meghana Keshavan — statnews.com


Merck Pays $400M for Cancer Drug Prospect From China-Based SciBrunch

Frank Vinluan — medcitynews.com


HUTCHMED Starts Global Phase 1 Trial Of KRAS-EGFR Therapy HMPL-A830 In Solid Tumors

RTTNews Staff Writer — rttnews.com

Execution: 2.15 Seconds. 31.81 mb used.